Cypress Capital Group’s Dentsply Sirona XRAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-6,681
Closed -$267K 310
2023
Q2
$267K Hold
6,681
0.04% 267
2023
Q1
$262K Buy
6,681
+350
+6% +$12.8K 0.04% 260
2022
Q4
$202K Buy
+6,331
New +$191K 0.03% 285
2022
Q1
Sell
-4,467
Closed -$249K 345
2021
Q4
$249K Sell
4,467
-116
-3% -$6.38K 0.03% 281
2021
Q3
$266K Hold
4,583
0.04% 247
2021
Q2
$290K Sell
4,583
-45
-1% -$2.96K 0.04% 243
2021
Q1
$295K Sell
4,628
-214
-4% -$12.4K 0.04% 240
2020
Q4
$254K Sell
4,842
-396
-8% -$19.5K 0.04% 241
2020
Q3
$229K Buy
5,238
+121
+2% +$5.35K 0.04% 237
2020
Q2
$225K Buy
+5,117
New +$216K 0.04% 228

Other funds holding XRAY

Cypress Capital Group's XRAY Position: Q3 2023 in Review

Cypress Capital Group sold out of Dentsply Sirona (XRAY) in Q3 2023, closing a stake of 6,681 shares — an estimated $267K sold.

Cypress Capital Group first reported a position in XRAY in Q2 2020 and held it in 10 quarters. The position peaked at $295K in Q1 2021. 474 funds tracked by Wall St. Rank hold XRAY as of Q3 2023.

  • Cypress Capital Group reported no remaining Dentsply Sirona position as of Q3 2023 after selling out during the quarter.
  • Cypress Capital Group sold 6,681 Dentsply Sirona shares in Q3 2023, an estimated $267K.
  • Cypress Capital Group first reported a position in Dentsply Sirona in Q2 2020 and held it in 10 quarters.
  • Cypress Capital Group's Dentsply Sirona position peaked at $295K in Q1 2021.
  • 474 funds tracked by Wall St. Rank held Dentsply Sirona as of Q3 2023.

Based on Cypress Capital Group's 13F filing for Q3 2023, filed 2 Nov 2023.